AHCC 연구회가 주최하고 일본 홋카이도 경제산업국과 주식회사 아미노업화학이 후원하는
 제25회 통합의료 기능성 식품 국제회의(ICNIM2017)가 개최되었습니다.
통합의료 기능성 식품 국제회의 ICNIM은 매년 일본 삿포로에서 열립니다.
AHCC를 필두로 주식회사 아미노업사의 원료를 가지고, 원료의 기능성을 연구, 임상실험을 진행하여
다양한 연구성과, 연구정보를 교환하는 의미 있는 자리입니다.
특히 이번 ICNIM2017에는 전 세계 28개국, 약 410여 명의 연구자, 관계자가 참가하였습니다.
 
 

 
기조강연으로는 영국 University of East Anglia의 Anne Marie Minihane 박사가
[유전자형 개별화 영양소와 헬시 에이징]이란 제목으로 ICNIM2017의 문을 열었습니다.

이번 ICNIM2017에서는 AHCC 예년과는 다른 특별한 이슈가 있었습니다.
AHCC가 미국 FDA로부터 메디컬푸드로 승인을 받았다는 소식입니다.
메디컬푸드란 FDA 약품법에 의해 관리되며, 질병 치료에 활용이 가능하고
 의사의 처방을 통해 섭취, 관리 가능한 식품을 말합니다.
문턱이 높기로 유명한 미국 FDA로부터의 메디컬푸드 승인은,
AHCC의 기능성과, 안전성에 대해 다시 한번 인정을 받았다고 평가할 수 있습니다.
 
 
 

 
July 8th (Saturday)
 
Opening Address  (2:30 pm)
 
Keynote Lecture  (2:45 pm ~ 3:30 pm)
 
“Genotype, personalised nutrition and healthy ageing: choose your parents carefully”
Anne Marie Minihane (University of East Anglia, UK)
 
Oral Session I  (3:30 pm ~ 5:50 pm)
 
“Investigating the effect of AHCC on immune checkpoint molecules in T cells”
Insoo Kang (Yale University, USA)
“Suppressive effects of AHCC on human renal carcinoma growth in super-SCID mice”
Taisei Nomura (National Institutes of Biomedical Innovation, Health and Nutrition, Japan)”
“The effects of AHCC on levels of CD4+ and CD8+ in patients with epithelial ovarian cancer or peritoneal cancer receiving platinum based chemotherapy”
Wichai Termrungruanglert (Chulalongkorn Hospital, Thailand)
“Effect of AHCC in women receiving adjuvant chemotherapy for breast cancer”
Satoru Iwase (The University of Tokyo, Japan)
“Oligonol attenuates muscle atrophy in diabetes”
Sue-Joan Chang (National Cheng Kung University, Taiwan)
“Beneficial effects of supplementation with Oligonol – without any dietary or lifestyle modifications – on cardiometabolic risk factors in a sample of overweight and obese Saudi females”
Suhad M. Bahijri (King Abdulaziz University, Saudi Arabia)
“Investigation of the amelioration effects of Oligonol on tinnitus in randomized double-blinded placebo-controlled trial”
Nobuaki Ito (Sain clarte Pharmaceutical Co., Ltd., Japan)
 
Poster Session  (6:00 pm ~ 7:00 pm)

“Alleviating effect of AHCC on endotoxin-induced liver injury after partial hepatectomy in rats”
Richi Nakatake (Kansai Medical University, Japan)
“Oral administration of AHCC on host protection during Zika virus infection”
Tian Wang (The University of Texas Medical Branch, USA)
“AHCC inhibits the proliferation of ovarian cancer cells by suppressing signal transducer and activator of transcription 3 (STAT3) activation”
Yong Beom Kim (Seoul National University Bundang Hospital, Korea)
“AHCC inhibits TGF-β-induced EMT in ARPE-19”
Kazuhiro Tokuda (Yamaguchi University, Japan)
“Effects of AHCC on the proliferation of human breast cancer cell line, MDA-MB-231”
Ryo Sakamoto (Ritsumeikan University, Japan)
“Evaluation of the synergic effect of AHCC and Wasabia japonica on human breast adenocarcinoma cells”
Bruna Corradetti (Marche Polytechnic University, Italy)
“Restoration of thyroid gland echo-structure by AHCC application”
Svetlana Bolshakova (Kazakh National University Named After S.D Asfendiyarov, Kazakhstan)”
“Reduction of adverse effects by AHCC in patients with advanced cancer during chemotherapy”
Satoshi Ohno (Osaka University, Japan)
“An impressive response to AHCC in a patient with squamous cell lung carcinoma”
Aiko Nagaoka (Omuta Hospital, Japan)
“Clinical outcomes of AHCC and its effect on chemotherapy related adverse events in patients with unresectable pancreatic cancer”
Anarkhuu Bold-Erdene (National Cancer Center of Mongolia, Mongolia)
“AHCC dosing: understanding research application of proof of concept studies to clinical practice”
Judith A. Smith (UTHealth McGovern Medical School, USA)
“Effects of AHCC on the stability of autonomic nervous system activity and immune functions during a stress response”
Hideaki Waki (Teikyo Heisei University, Japan)
“Effects of AHCC supplementation on Lyme disease patients”
John Salerno (The Salerno Center for Complementary Medicine, USA)
“The reduction of cardiovascular events in patients with stable coronary disease receiving therapeutic administration of AHCC”
Veronica Di Nardo (Marconi University, Italy)
“Isolation and identification of components of Oligonol”
Takehiro Kashiwagi (Kochi University, Japan)
“Investigation of condition for exerting in vivo activity using low concentration Oligonol”
Kazumi Hayama (Teikyo University, Japan)
“Effect of catechin-type monomers and proanthocyanidin oligomers derived from Oligonol on anti-diabetic, anti-Alzheimer’s disease and anti-Parkinson’s disease potential”
Su Hui Seong (Pukyong National University, Korea)
“Effects of combination of Oligonol and conjugated linoleic acid intake on lipid metabolism in rats”
Kyoichi Osada (Meiji University, Japan)
“Assessing cryopreservation of mesenchymal stem cells using Oligonol”
Byron Baron (University of Malta, Malta)
“Effect of Oligonol on aging phenomena using vitamin C synthesis-deficient mice”
Koji Wakame (Hokkaido Pharmaceutical University, Japan)
“The fatigue reducing effect of Oligonol”
Masaki Taga (Wayo Women’s University, Japan)
“Effect of Oligonol in the symptoms of patients with depression”
Masahiko Tatsumi (Yokohama Shinryo Clinic, Japan)
“ETAS has suppressive effect on ultraviolet-B radiation-induced NF-κB nuclear translocation in normal human dermal fibroblasts”
Ken Shirato (Kyorin University, Japan)
“Protective effects of ETAS on UV-B-irradiated keratinocytes”
Tomoko Koda (Tokyo Healthcare University, Japan)
“ETAS prevents loss of spatial-working memory in Alzheimer model mice”
Serina Tokita (Sapporo Medical University, Japan)
“Effects of food containing asparagus extract (ONR-8) on sleep in healthy adults”
Manami Kato (Otsuka Pharmaceutical Co., Ltd., Japan)
“A new bioassay using insects to evaluate stress-resistance induction activity of dietary supplement contents”
Takashi Matsumura (Saga University, Japan)
“Determination of the effect of perilla extract on NRF2 activity using an ARE-luciferase sensor”
Byron Baron (University of Malta, Malta)
“The effect of Perilla frutescens extract ingestion on downhill running-induced muscle damage and inflammatory response”
Aoi Ikedo (Ritsumeikan University, Japan)
“Women: The paradigms of the looks; why hormones change before menopause”
Francisco Karkow (Fatima’s Faculty Caxias do Sul, Brazil)
“Effect of Peucedanum japonicum Thunb on metabolic syndrome in the Okinawa Prefecture, Japan”
Miki Sakaue (Osaka University, Japan)
“Sortilin-related receptor 1 interacts with amyloid precursor protein and is activated by 6-shogaol, leading to inhibition of the amyloidogenic pathway”
Jungkee Kwon (Chonbuk National University, Korea)
“Gene expression of antioxidant enzymes by antioxidant from Pacific oyster”
Hirotoshi Fuda (Hokkaido University, Japan)
“Effects of Cirsium brevicaule A. GRAY “KousyunsouR” on lipid metabolism and its active compounds”
Masashi Inafuku (University of the Ryukyus, Japan)
“Suppressive effect of mulberry leaf (Morus bombycis) powder on metabolic syndrome －Comprehensive gene expression analysis by RNA sequencesing－”
Koji Wakame (Hokkaido Pharmaceutical University, Japan)
“Effects of the extracts from Indonesian and Japanese bitter melons on nitric oxide production in hepatocytes”
Dinia Rizqi Dwijayanti (Ritsumeikan University, Japan)
“Evaluation of efficacy and toxicity for dormancy-breaking grape seed supplement against pancreatic cancer”
Toshihiro Ona (Kyushu University, Japan)
“Development of a novel functional alternative sweetener which contributes to the prevention and the treatment of diabetes”
Akifumi Uemura (WAKAN, Ltd., Japan)
“Curcumin counteracts epigenetic suppression of 15-hydroxyprostaglandin dehydrogenase expression induced by Helicobacter pylori”
Hye-Kyung Na (Sungshin Women’s University, Korea)
“Serotonin and its derivatives of safflower seed play a key role in anti-inflammatory and anti-apoptotic effects in anticancer drug-induced nephrotoxicity”
Chan Hum Park (National Institute of Horticultural and Herbal Science, Korea)
 
July 9th (Sunday)
 
Oral Session II  (9:00 am ~ noon)
 
“Neuroprotective effects of ETAS in APP overexpressed mice”
Marie-Francoise Doursout (University of Texas, USA)
“The clinical study about effect of ETAS on dementia”
Takayuki Zenimoto (Japan Health Care College, Japan)
“ETAS treatment results for children with cognitive and behavior disorders”
Natalia Mikhailichenko (International Medical Center “Nevron”, Russia)
 
“Constituents in perilla extract inhibit production of nitric oxide in rat hepatocytes”
Yukinobu Ikeya (Daiichi University of Pharmacy, Japan)
“Anti-inflammatory and pro-resolving effects of the Perilla frutescens extract”
Young-Joon Surh (Seoul National University, Korea)
“Integrate oncology and a novel nutritional supplement “AHCC and Wasabia japonica extract”: review of cases reports”
Ivano Hammarberg Ferri (Outpatient Integrative Oncology IHF, Italy)
“High risk HPV infections: where we have been; where we are today and where we are going next”
Judith A. Smith (UTHealth McGovern Medical School, USA)
“AHCC for potential treatment of pulmonary tuberculosis in HIV-infected patients”
Elly Wahyudin (Hasanuddin University, Indonesia)
“The effect of Ipomoea aquatica ingestion on dyslipidemia”
Yoko Sakamoto (Osaka University, Japan)
“Protective effects of lactoferrin against common infections such as norovirus gastroenteritis”
Hiroyuki Wakabayashi (Morinaga Milk Industry Co., Ltd., Japan)
General Discussion  (1:00 pm ~ 3:00 pm)
Closing Address  (3:00 pm)